Dr. Ginsberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
MC 8409
San Diego, CA 92103Phone+1 619-543-4619
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2012 - 2015
- Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
- CA State Medical License 2015 - 2026
- MO State Medical License 2014 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Phosphate Microvascular Study Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- 15 citationsFGF23, Frailty, and Falls in SPRINTAnna Jovanovich, Charles Ginsberg, Zhiying You, Ronit Katz, Walter T. Ambrosius
Journal of the American Geriatrics Society. 2021-02-01 - 21 citationsThe Vitamin D Metabolite Ratio Is Independent of Vitamin D Binding Protein ConcentrationCharles Ginsberg, Andrew N. Hoofnagle, Ronit Katz, Jessica O. Becker, Stephen B. Kritchevsky
Clinical Chemistry. 2021-01-30 - 23 citationsThe Vitamin D Metabolite Ratio Is Associated With Changes in Bone Density and Fracture Risk in Older Adults.Charles Ginsberg, Andrew N. Hoofnagle, Ronit Katz, Jan M. Hughes-Austin, Lindsay M Miller
Journal of Bone and Mineral Research. 2021-08-29
Journal Articles
- PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTUdayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology
Press Mentions
- Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial ResultsAugust 11th, 2021
- Navidea Biopharmaceuticals Announces NIH Grant Award to UC San Diego for Clinical Study Evaluating Tc99m Tilmanocept as a Kidney Imaging AgentMay 11th, 2021
- Elevated Phosphate May Be Detrimental Even Without CKDOctober 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: